Avanos Medical, Inc. (NYSE:AVNS) Shares Bought by Northern Trust Corp

Northern Trust Corp increased its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 4.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 526,763 shares of the company's stock after buying an additional 24,720 shares during the quarter. Northern Trust Corp owned about 1.15% of Avanos Medical worth $8,386,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of AVNS. Tudor Investment Corp ET AL purchased a new position in shares of Avanos Medical during the fourth quarter worth $519,000. Aquatic Capital Management LLC boosted its holdings in Avanos Medical by 86.6% in the 4th quarter. Aquatic Capital Management LLC now owns 21,274 shares of the company's stock worth $339,000 after buying an additional 9,874 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in Avanos Medical by 27.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company's stock worth $47,941,000 after buying an additional 644,267 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock worth $129,000 after buying an additional 6,714 shares during the last quarter. Finally, First Trust Advisors LP acquired a new stake in Avanos Medical in the 4th quarter worth about $1,234,000. Institutional investors and hedge funds own 95.17% of the company's stock.

Avanos Medical Price Performance

AVNS stock traded down $0.40 during mid-day trading on Wednesday, reaching $12.70. The company's stock had a trading volume of 402,232 shares, compared to its average volume of 358,565. The stock has a market cap of $587.30 million, a PE ratio of 37.35 and a beta of 1.13. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $25.36. The company's 50 day moving average is $13.10 and its two-hundred day moving average is $15.62.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The company had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Avanos Medical's quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 EPS. Equities research analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. This represents a 7.86% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.64% of the stock is owned by company insiders.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.